Sunil Healthcare (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Sunil Healthcare Limited |
|||
|
Price: ₹81.29 | ||
| 52 Week Low: ₹52.70 52 Week High: ₹104.00 |
|||
| Market Capital: 83.62 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Sunil Healthcare Share Price Target For 2024
- 1.1.1: Sunil Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Sunil Healthcare Share Price Target For 2025
- 1.2.1: Sunil Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Sunil Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Sunil Healthcare Financial Performance
- 3.0.1: Is Sunil Healthcare A Good Buy For Long Term?
To predict the Sunil Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sunil Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Sunil Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sunil Healthcare shares in 2024, see the table below.
Sunil Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 86.9 (+6.9%) | Price Action: 27 Jun 2024 Low |
| 2024 Target 2 | 85.88 (+5.64%) | Price Action: 11 Nov 2024 High |
| 2024 Target 1 | 85.0 (+4.55%) | Price Action: 20 Aug 2024 Low |
| Current Price | 81.29 | Sunil Healthcare's share price as of 26 Dec 2024 |
| Stop Loss 1 | 79.61 (-2.06%) | Price Action: 18 Nov 2024 High |
| Stop Loss 2 | 78.8 (-3.07%) | Price Action: 04 Jun 2024 High |
| Stop Loss 3 | 78.0 (-4.05%) | Price Action: Feb 2024 High |
Short-Term Technical Outlook
Current Technical Position: Sunil Healthcare is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹80.85 serves as the nearest technical reference point.
Historical Returns: 3-month: -7.83% | 6-month: -7.65% | 1-year: +48.31%
Sunil Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Sunil Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sunil Healthcare shares in 2025, see the table below.
Sunil Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 119.0 (+46.38%) | Price Action: Chart |
| 2025 Target 2 | 116.78 (+43.65%) | Price Action: Chart |
| 2025 Target 1 | 115.62 (+42.23%) | Fibonacci Extension Level 64.90% |
| Current Price | 81.29 | Sunil Healthcare's share price as of 26 Dec 2024 |
| Stop Loss 1 | 73.12 (-10.06%) | Price Action: 25 Nov 2024 Low |
| Stop Loss 2 | 72.25 (-11.13%) | Price Action: Jan 2015 High |
| Stop Loss 3 | 71.4 (-12.17%) | Price Action: 11 Mar 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Sunil Healthcare is currently trading at 55.7% of its 52-week range (₹52.7 - ₹104).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +48.31% | 3-year: +94.94% | 5-year: +254.2%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sunil Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹81.29 | ||
| 2024 | ₹89.49 | +10.08% | ₹90.83 |
| 2025 | ₹86.28 | -3.58% | ₹91.57 |
| 2026 | ₹86.82 | +0.62% | ₹94.07 |
| 2027 | ₹88.03 | +1.39% | ₹96.57 |
| 2028 | ₹96.62 | +9.75% | ₹99.07 |
| 2029 | ₹99.28 | +2.75% | ₹100.77 |
| 2030 | ₹95.52 | -3.78% | ₹99.05 |
| 2031 | ₹95.92 | +0.41% | ₹99.72 |
| 2032 | ₹97.07 | +1.19% | ₹98.78 |
| 2033 | ₹106.34 | +9.54% | ₹107.94 |
| 2034 | ₹109.07 | +2.56% | ₹110.71 |
| 2035 | ₹104.76 | -3.95% | ₹106.33 |
| 2036 | ₹105.02 | +0.24% | ₹106.60 |
| 2037 | ₹106.11 | +1.03% | ₹116.58 |
| 2038 | ₹116.06 | +9.37% | ₹117.80 |
| 2039 | ₹109.53 | -5.62% | ₹116.57 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Sunil Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 83.62 Crore | Market valuation of Sunil Healthcare's shares. |
| Revenue (TTM) | 110.45 Crore | Total revenue generated by Sunil Healthcare over the past twelve months. |
| Net Income (TTM) | +6.68 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +11.6% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +53.73% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-4.36% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.9 | Company's total debt divided by total shareholder equity. |
| Total Debt | 48.99 Crore | Sum of Sunil Healthcare's current & long-term financial obligations. |
Is Sunil Healthcare A Good Buy For Long Term?
Based on the given information, Sunil Healthcare appears to be a strong long-term investment option. It has a healthy profit margin of 53.73%, indicating efficient expense management and profitability. Over the past five years, the company has generated impressive returns of 56.82%, demonstrating consistent growth. However, it is important to note that the stock has a small market capitalization and has experienced a recent decline in revenue. Investors should carefully consider these factors before making a decision.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
